Efficacy and safety of an amino acid jelly containing coenzyme Q10 and l-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01)

Supportive Care in Cancer

Volumn 24, Issue 2, 2016, Pages 637-646

  Iwase, Satoru ^a   Kawaguchi, Takashi ^b   Yotsumoto, Daisuke ^c   Doi, Takako ^d   Miyara, Kyuichiro ^e   Odagiri, Hiroki ^f   Kitamura, Kaoru ^g   Ariyoshi, Keisuke ^a,h   Miyaji, Tempei ^h,i   Ishiki, Hiroto ^a,h   Inoue, Kenichi ^d   Tsutsumi, Chizuko ^d   Sagara, Yoshiaki ^c   Yamaguchi, Takuhiro ^h,i,j  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^c SAGARA HOSPITAL   (Japan)

^d Kamakura Breast Cancer Center   (Japan)

^e Miyara Clinic   (Japan)

^f HIROSAKI NATIONAL HOSPITAL   (Japan)

^g Breast Unit   (Japan)

^h JORTC Data Center   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Cancer related fatigue; Chemotherapy induced fatigue; Complementary and alternative medicine; Quality of life; Supplement

Indexed keywords

AMINO ACID; CARNITINE; INNER POWER; UBIDECARENONE; UNCLASSIFIED DRUG; UBIQUINONE;

ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ANXIETY; ARTHRALGIA; ARTICLE; ASSESSMENT OF HUMANS; BREAST CANCER; BRIEF FATIGUE INVENTORY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RELATED FATIGUE; CLINICAL ASSESSMENT; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIET SUPPLEMENTATION; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; DYSGEUSIA; EPIPHORA; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE CORE 30; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; GASTRITIS; HEART PALPITATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFECTION; INTERVENTION STUDY; INVESTIGATIVE PROCEDURES; JAPAN; LEUKOPENIA; LIP DISEASE; LIP INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; ORAL MUCOSITIS; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PERIPHERAL SENSORY NEUROPATHY; PHLEBITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; THROMBOCYTOPENIA; VOMITING; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; CLINICAL TRIAL; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; BREAST NEOPLASMS; CARNITINE; FATIGUE; FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; UBIQUINONE;

EID: 84952873909     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2824-4     Document Type: Article

References (41)

1. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 14:151–161
2. Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manag 18:233–242
3. Gaston-Johansson F, Fall-Dickson JM, Bakos AB, Kennedy MJ (1999) Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract 7:240–247
4. Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A'Hern R (1999) Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer 79:1479–1486
5. Jacobsen PB, Donovan KA, Small BJ, Jim HS, Munster PN, Andrykowski MA (2007) Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer 110:1851–1859
6. Gutstein HB (2001) The biologic basis of fatigue. Cancer 92:1678–1683
7. Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183
8. Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, Mikami I, Hosaka T, Uchitomi Y (2000) Factors correlated with fatigue in disease-free breast cancer patients: application of the cancer fatigue scale. Support Care Cancer 8:215–222
9. Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, Dalal S, Massie L, Reddy SK, Bruera E (2013) Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31:3076–3082
10. Horneber M, Fischer I, Dimeo F, Ruffer JU, Weis J (2012) Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int 109:161–171 quiz 172
11. Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, Suh JJ, Griffin PC, Johnson DB, Ali A, Silberstein PT, Duane SF, Loprinzi CL (2010) Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central cancer treatment group NCCTG-N05C7 trial. J Clin Oncol 28:3673–3679
12. Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D (2009) Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manag 38:650–662
13. Auret KA, Schug SA, Bremner AP, Bulsara M (2009) A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. J Pain Symptom Manag 37:613–621
14. Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, Peppone L, Hemstad A, Esparaz BT, Hopkins JO (2010) A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 116:3513–3520
15. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, Kaptchuk TJ, Eisenberg DM (2001) Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135:262–268
16. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733–1739
17. Sood A, Barton DL, Bauer BA, Loprinzi CL (2007) A critical review of complementary therapies for cancer-related fatigue. Integr Cancer Ther 6:8–13
18. Higashiguchi T, Futamura A, Ito A (2010) Effect of a complementary nutrition diet for improving clinical condition and function in terminal cancer patients: a controlled clinical trial. JJSMN 44:157–169
19. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR (2007) Mechanisms of cancer-related fatigue. Oncologist 12(Suppl 1):22–34
20. Mizuno K, Tanaka M, Nozaki S, Mizuma H, Ataka S, Tahara T, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, Kajimoto O, Watanabe Y (2008) Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition 24:293–299
21. Gramignano G, Lusso MR, Madeddu C, Massa E, Serpe R, Deiana L, Lamonica G, Dessi M, Spiga C, Astara G, Maccio A, Mantovani G (2006) Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition 22:136–145
22. Malaguarnera M, Cammalleri L, Gargante MP, Vacante M, Colonna V, Motta M (2007) L-carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr 86:1738–1744
23. Blomstrand E (2006) A role for branched-chain amino acids in reducing central fatigue. J Nutr 136:544s–547s
24. Astin JA (1998) Why patients use alternative medicine: results of a national study. JAMA 279:1548–1553
25. Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH, Ogaily MS, Pirl WF, Jacobsen PB (2014) Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol 32:1840–1850
26. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85:1186–1196
27. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y (2003) Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manag 25:106–117
28. Johnston M, Pollard B, Hennessey P (2000) Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 48:579–584
29. Matsudaira T, Igarashi H, Kikuchi H, Kano R, Mitoma H, Ohuchi K, Kitamura T (2009) Factor structure of the hospital anxiety and depression scale in Japanese psychiatric outpatient and student populations. Health Qual Life Outcomes 7:42
30. Kobayashi K, Takeda F, Teramukai S, Gotoh I, Sakai H, Yoneda S, Noguchi Y, Ogasawara H, Yoshida K (1998) A cross-validation of the European organization for research and treatment of cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer (Oxf) 34:810–815
31. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osaba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
32. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324:1417
33. Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK (1996) The European organization for research and treatment of cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756–2768
34. Okamoto T, Shimozuma K, Katsumata N, Koike M, Hisashige A, Tanaka K, Ohsumi S, Saito M, Shikama N, Mitsumori M, Yamauchi C, Watanabe T (2003) Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in Japan. Breast Cancer (Tokyo) 10:204–213
35. Brown E, Hurlow A, Rahman A, Closs SJ, Bennett MI (2010) Assessment of fatigue after blood transfusion in palliative care patients: a feasibility study. J Palliat Med 13:1327–1330
36. World Medical Association Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects 2008. http://www.wma.net/en/30publications/10policies/b3/ Accessed: 3 Dec 2014
37. The Ethical Guidelines for Clinical Research (Ministry of Labor, Health, and Welfare of Japan). http://www.mhlw.go.jp/general/seido/kousei/i-kenkyu/rinsyo/dl/shishin.pdf. Accessed: 3 Dec 2014
38. Ishiki H, Iwase S, Gyoda Y, Kanai Y, Ariyoshi K, Miyaji T, Tahara Y, Kawaguchi T, Chinzei M, Yamaguchi T (2015) Oral nutritional support can shorten the duration of parenteral hydration in end-of-life cancer patients: a randomized controlled trial. Nutr Cancer 67:105–111
39. Lesser GJ, Case D, Stark N, Williford S, Giguere J, Garino LA, Naughton MJ, Vitolins MZ, Lively MO, Shaw EG, Wake Forest University Community Clinical Oncology Program Research B (2013) A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer. J Support Oncol 11:31–42
40. Cruciani RA, Zhang JJ, Manola J, Cella D, Ansari B, Fisch MJ (2012) l-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol 30:3864–3869
41. Patient-Reported Outcomes (Society for Clinical Data Management’s Good Clinical Data Management Practices). http://www.scdm.org/ Accessed: 3 Dec